Non-Hemorrhagic Shock - Revision history

Treloars at 20:02, 22 April 2020

2020-04-22T20:02:52Z

← Older revision		Revision as of 20:02, 22 April 2020
Line 9:		Line 9:
	* Establish 2 large bore IV lines. Fluid boluses in increments of 200 - 300 ml, to titrate systolic BP greater than 90 mm Hg. Monitor for signs of fluid overload.		* Establish 2 large bore IV lines. Fluid boluses in increments of 200 - 300 ml, to titrate systolic BP greater than 90 mm Hg. Monitor for signs of fluid overload.
	* Limit fluid administration to 2000cc due to possibility of DIC.		* Limit fluid administration to 2000cc due to possibility of DIC.
	* In non-hemorrhagic shock, if condition worsens despite fluid therapy, administer [[~~Adrenergics~~\|DOPAMINE]] 5 - 20 mcg/kg/minute titrated to systolic BP greater than 90 mm Hg.		* In non-hemorrhagic shock, if condition worsens despite fluid therapy, administer [[Dopamine\|DOPAMINE]] 5 - 20 mcg/kg/minute titrated to systolic BP greater than 90 mm Hg.

Treloars: /* HYPOTENSION WITH SIGNS OF DECREASED TISSUE PERFUSION NOT SECONDARY TO BLOOD LOSS */

2018-10-01T20:37:18Z

HYPOTENSION WITH SIGNS OF DECREASED TISSUE PERFUSION NOT SECONDARY TO BLOOD LOSS

← Older revision		Revision as of 20:37, 1 October 2018
Line 9:		Line 9:
	* Establish 2 large bore IV lines. Fluid boluses in increments of 200 - 300 ml, to titrate systolic BP greater than 90 mm Hg. Monitor for signs of fluid overload.		* Establish 2 large bore IV lines. Fluid boluses in increments of 200 - 300 ml, to titrate systolic BP greater than 90 mm Hg. Monitor for signs of fluid overload.
	* Limit fluid administration to 2000cc due to possibility of DIC.		* Limit fluid administration to 2000cc due to possibility of DIC.
	* If known hemorrhagic shock infuse fluid rapidly until systolic BP greater than 90 mm Hg. Monitor patient for signs of fluid overload.
	* In non-hemorrhagic shock, if condition worsens despite fluid therapy, administer [[Adrenergics\|DOPAMINE]] 5 - 20 mcg/kg/minute titrated to systolic BP greater than 90 mm Hg.		* In non-hemorrhagic shock, if condition worsens despite fluid therapy, administer [[Adrenergics\|DOPAMINE]] 5 - 20 mcg/kg/minute titrated to systolic BP greater than 90 mm Hg.

Treloars: Treloars moved page Shock to Non-Hemorrhagic Shock: Split trauma and medical shock.

2018-10-01T20:34:41Z

Treloars moved page Shock to Non-Hemorrhagic Shock: Split trauma and medical shock.

← Older revision	Revision as of 20:34, 1 October 2018
(No difference)

Treloars at 20:28, 1 October 2018

2018-10-01T20:28:57Z

← Older revision		Revision as of 20:28, 1 October 2018
Line 1:		Line 1:
	== Section 5 -MEDICAL ==		== Section 5 - MEDICAL ==
	=== 5.13 SHOCK ===		=== 5.13 NON-HEMORRHAGIC SHOCK ===
	=== HYPOTENSION WITH SIGNS OF DECREASED TISSUE PERFUSION NOT SECONDARY TO BLOOD LOSS ===		=== HYPOTENSION WITH SIGNS OF DECREASED TISSUE PERFUSION NOT SECONDARY TO BLOOD LOSS ===

Treloars at 20:28, 1 October 2018

2018-10-01T20:28:06Z

← Older revision		Revision as of 20:28, 1 October 2018
Line 1:		Line 1:
	== Section 5 -MEDICAL ==		== Section 5 -MEDICAL ==
	=== 5.13 SHOCK ===		=== 5.13 SHOCK ===
	=== HYPOTENSION WITH SIGNS OF DECREASED TISSUE PERFUSION SECONDARY TO ~~FLUID~~ LOSS ===		=== HYPOTENSION WITH SIGNS OF DECREASED TISSUE PERFUSION NOT SECONDARY TO BLOOD LOSS ===

	INITIAL MEDICAL CARE - Provide OXYGEN or assist ventilations as appropriate for patient condition.		INITIAL MEDICAL CARE - Provide OXYGEN or assist ventilations as appropriate for patient condition.
Line 7:		Line 7:
	* Control any external hemorrhage if present		* Control any external hemorrhage if present
	* For spontaneously breathing patients with a systolic blood pressure less than 100 mm Hg and no known contraindications to the device, apply the [[ResQGuard Impedance Threshold Device\|ResQGuard impedance threshold device]] with mask or mouth-piece as indicated (procedure 9.31) if available. Monitor systolic Blood pressure every 2-3 minutes.		* For spontaneously breathing patients with a systolic blood pressure less than 100 mm Hg and no known contraindications to the device, apply the [[ResQGuard Impedance Threshold Device\|ResQGuard impedance threshold device]] with mask or mouth-piece as indicated (procedure 9.31) if available. Monitor systolic Blood pressure every 2-3 minutes.
	* Consider administration of [[Anti-Fibrinolytic\|Tranexamic Acid (TXA)]] if:
	** Sustained Systolic Blood Pressure is less than 90 mmHg AND
	** Sustained heart rate of 110 beats per minute or higher
	* Establish 2 large bore IV lines. Fluid boluses in increments of 200 - 300 ml, to titrate systolic BP greater than 90 mm Hg. Monitor for signs of fluid overload.		* Establish 2 large bore IV lines. Fluid boluses in increments of 200 - 300 ml, to titrate systolic BP greater than 90 mm Hg. Monitor for signs of fluid overload.
	* Limit fluid administration to 2000cc due to possibility of DIC.		* Limit fluid administration to 2000cc due to possibility of DIC.

Treloars: /* Section 5 -MEDICAL */

2018-08-27T20:47:51Z

Section 5 -MEDICAL

← Older revision		Revision as of 20:47, 27 August 2018
Line 7:		Line 7:
	* Control any external hemorrhage if present		* Control any external hemorrhage if present
	* For spontaneously breathing patients with a systolic blood pressure less than 100 mm Hg and no known contraindications to the device, apply the [[ResQGuard Impedance Threshold Device\|ResQGuard impedance threshold device]] with mask or mouth-piece as indicated (procedure 9.31) if available. Monitor systolic Blood pressure every 2-3 minutes.		* For spontaneously breathing patients with a systolic blood pressure less than 100 mm Hg and no known contraindications to the device, apply the [[ResQGuard Impedance Threshold Device\|ResQGuard impedance threshold device]] with mask or mouth-piece as indicated (procedure 9.31) if available. Monitor systolic Blood pressure every 2-3 minutes.
	* Consider administration of Tranexamic Acid (TXA) if:		* Consider administration of [[Anti-Fibrinolytic\|Tranexamic Acid (TXA)]] if:
	** Sustained Systolic Blood Pressure is less than 90 mmHg AND		** Sustained Systolic Blood Pressure is less than 90 mmHg AND
	** Sustained heart rate of 110 beats per minute or higher		** Sustained heart rate of 110 beats per minute or higher

Treloars at 20:28, 27 August 2018

2018-08-27T20:28:26Z

← Older revision		Revision as of 20:28, 27 August 2018
Line 7:		Line 7:
	* Control any external hemorrhage if present		* Control any external hemorrhage if present
	* For spontaneously breathing patients with a systolic blood pressure less than 100 mm Hg and no known contraindications to the device, apply the [[ResQGuard Impedance Threshold Device\|ResQGuard impedance threshold device]] with mask or mouth-piece as indicated (procedure 9.31) if available. Monitor systolic Blood pressure every 2-3 minutes.		* For spontaneously breathing patients with a systolic blood pressure less than 100 mm Hg and no known contraindications to the device, apply the [[ResQGuard Impedance Threshold Device\|ResQGuard impedance threshold device]] with mask or mouth-piece as indicated (procedure 9.31) if available. Monitor systolic Blood pressure every 2-3 minutes.
			* Consider administration of Tranexamic Acid (TXA) if:
			** Sustained Systolic Blood Pressure is less than 90 mmHg AND
			** Sustained heart rate of 110 beats per minute or higher
	* Establish 2 large bore IV lines. Fluid boluses in increments of 200 - 300 ml, to titrate systolic BP greater than 90 mm Hg. Monitor for signs of fluid overload.		* Establish 2 large bore IV lines. Fluid boluses in increments of 200 - 300 ml, to titrate systolic BP greater than 90 mm Hg. Monitor for signs of fluid overload.
	* Limit fluid administration to 2000cc due to possibility of DIC.		* Limit fluid administration to 2000cc due to possibility of DIC.

Treloars at 02:16, 31 January 2018

2018-01-31T02:16:53Z

← Older revision		Revision as of 02:16, 31 January 2018
Line 16:		Line 16:


	[[Category:Medical]]		[[Category:Medical\|0513]]

Treloars at 01:38, 31 January 2018

2018-01-31T01:38:12Z

← Older revision		Revision as of 01:38, 31 January 2018
Line 14:		Line 14:

	'''''ADMINISTRATION OF DOPAMINE TO HYPOVOLEMIC PATIENTS IS CONTRAINDICATED.'''''		'''''ADMINISTRATION OF DOPAMINE TO HYPOVOLEMIC PATIENTS IS CONTRAINDICATED.'''''


			[[Category:Medical]]

Treloars: /* HYPOTENSION WITH SIGNS OF DECREASED TISSUE PERFUSION SECONDARY TO FLUID LOSS */

2012-03-17T21:17:36Z

HYPOTENSION WITH SIGNS OF DECREASED TISSUE PERFUSION SECONDARY TO FLUID LOSS

← Older revision		Revision as of 21:17, 17 March 2012
Line 6:		Line 6:
	* Place patient in Trendelenburg		* Place patient in Trendelenburg
	* Control any external hemorrhage if present		* Control any external hemorrhage if present
	* For spontaneously breathing patients with a systolic blood pressure less than 100 mm Hg and no known contraindications to the device, apply the [[ResQGuard]] impedance threshold device with mask or mouth-piece as indicated (procedure 9.31) if available. Monitor systolic Blood pressure every 2-3 minutes.		* For spontaneously breathing patients with a systolic blood pressure less than 100 mm Hg and no known contraindications to the device, apply the [[ResQGuard Impedance Threshold Device\|ResQGuard impedance threshold device]] with mask or mouth-piece as indicated (procedure 9.31) if available. Monitor systolic Blood pressure every 2-3 minutes.
	* Establish 2 large bore IV lines. Fluid boluses in increments of 200 - 300 ml, to titrate systolic BP greater than 90 mm Hg. Monitor for signs of fluid overload.		* Establish 2 large bore IV lines. Fluid boluses in increments of 200 - 300 ml, to titrate systolic BP greater than 90 mm Hg. Monitor for signs of fluid overload.
	* Limit fluid administration to 2000cc due to possibility of DIC.		* Limit fluid administration to 2000cc due to possibility of DIC.